(Q43000517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Ángeles O Angela Ruiz-Extremera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Javier Salmerón

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Paloma Muñoz De Rueda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jorge Casado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Carlos Huertas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maria Del Carmen Bernal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Luis Rodríguez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Angel Palacios

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

960-967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16758308%20AND%20SRC:MED&resulttype=core&format=json

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

29 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9347-2

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9347-2

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

21 January 2018

1 reference

12 December 2020

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

1 reference

12 December 2020

Combined therapy with interferon and ribavirin in chronic hepatitis C does not affect serum quasispecies diversity

1 reference

12 December 2020

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

1 reference

12 December 2020

Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions

1 reference

12 December 2020

Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients

1 reference

12 December 2020

The scientific challenge of hepatitis C.

1 reference

12 December 2020

Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

1 reference

12 December 2020

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.

1 reference

12 December 2020

Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

1 reference

12 December 2020

Factors predictive of a beneficial response to therapy of hepatitis C.

1 reference

12 December 2020

Classification of chronic viral hepatitis: a need for reassessment

1 reference

12 December 2020

Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.

1 reference

12 December 2020

Optimisation and sensitivity of single-stranded conformation polymorphism for the detection of hepatitis C virus quasi-species

1 reference

12 December 2020

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

1 reference

12 December 2020

The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy

1 reference

12 December 2020

Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies

1 reference

12 December 2020

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].

1 reference

12 December 2020

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

1 reference

12 December 2020

Hepatitis C virus resistance to antiviral therapy.

1 reference

12 December 2020

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

12 December 2020

[Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy]

1 reference

12 December 2020

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

12 December 2020

Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus

1 reference

12 December 2020

Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy.

1 reference

12 December 2020

Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.

1 reference

12 December 2020

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen

1 reference

12 December 2020

Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy

1 reference

12 December 2020

Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon

1 reference

12 December 2020

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment

1 reference

12 December 2020

Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study

1 reference

12 December 2020

Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection.

1 reference

12 December 2020

Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.

1 reference

12 December 2020

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

12 December 2020